Outcome of ART cycles with the use of corifollitropin alfa and daily recombinant FSH in patients stratified by low (<1.0 ng/mL), moderate (1.0–3.36 ng /mL), and high (> 3.36 ng/mL) AMH levels.
收藏NIAID Data Ecosystem2026-03-10 收录
数据链接：
官方服务：
资源简介：
Outcome of ART cycles with the use of corifollitropin alfa and daily recombinant FSH in patients stratified by low (<1.0 ng/mL), moderate (1.0–3.36 ng /mL), and high (> 3.36 ng/mL) AMH levels.
创建时间：
2018-11-14
